SCHIPPA, Serena
 Distribuzione geografica
Continente #
EU - Europa 12.766
NA - Nord America 5.225
AS - Asia 1.279
SA - Sud America 127
AF - Africa 92
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 1
Totale 19.504
Nazione #
RO - Romania 10.716
US - Stati Uniti d'America 4.983
IT - Italia 902
SG - Singapore 421
IN - India 324
CN - Cina 260
SE - Svezia 232
UA - Ucraina 191
FI - Finlandia 156
MX - Messico 142
DE - Germania 126
GB - Regno Unito 109
CA - Canada 70
ES - Italia 70
IE - Irlanda 58
MY - Malesia 52
FR - Francia 51
KR - Corea 45
AR - Argentina 39
BR - Brasile 35
ID - Indonesia 35
BE - Belgio 29
EG - Egitto 25
TR - Turchia 25
TG - Togo 24
BG - Bulgaria 23
CO - Colombia 15
DZ - Algeria 15
PH - Filippine 15
PL - Polonia 15
TW - Taiwan 15
CL - Cile 14
NL - Olanda 14
CZ - Repubblica Ceca 12
HK - Hong Kong 12
IQ - Iraq 12
BZ - Belize 10
CH - Svizzera 10
GR - Grecia 10
JP - Giappone 10
BJ - Benin 9
GT - Guatemala 9
TH - Thailandia 9
AT - Austria 8
AU - Australia 8
CR - Costa Rica 8
EC - Ecuador 8
IR - Iran 8
PT - Portogallo 8
PE - Perù 7
BD - Bangladesh 6
NG - Nigeria 6
NZ - Nuova Zelanda 6
PK - Pakistan 6
JO - Giordania 5
BO - Bolivia 4
LK - Sri Lanka 4
LT - Lituania 4
SA - Arabia Saudita 4
GH - Ghana 3
HU - Ungheria 3
KE - Kenya 3
LV - Lettonia 3
MK - Macedonia 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
VN - Vietnam 3
DK - Danimarca 2
EE - Estonia 2
HN - Honduras 2
HR - Croazia 2
KG - Kirghizistan 2
LB - Libano 2
MA - Marocco 2
NO - Norvegia 2
PY - Paraguay 2
RU - Federazione Russa 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
EU - Europa 1
IL - Israele 1
JM - Giamaica 1
QA - Qatar 1
Totale 19.504
Città #
Horia 10.696
Fairfield 651
Chandler 428
Ashburn 389
Woodbridge 363
Singapore 327
Rome 282
Seattle 271
Houston 246
Cambridge 219
Wilmington 213
Ann Arbor 191
Dearborn 177
Princeton 134
New York 131
Beijing 118
Plano 113
Santa Clara 88
Jacksonville 80
Boston 78
Lawrence 67
San Paolo di Civitate 64
Dublin 57
Milan 52
Millbury 46
Helsinki 45
Andover 44
San Diego 41
Des Moines 31
Fremont 29
Toronto 29
Jakarta 28
Federal 27
San Mateo 27
Boardman 25
Bradford 25
Lomé 24
Guadalajara 23
San Jose 22
Sofia 22
Bremen 18
Norwalk 18
Frankfurt am Main 17
Nanjing 17
Florence 16
Hefei 16
Mexico City 16
Brussels 15
Ottawa 15
Bologna 13
Leeds 13
London 12
Padova 12
Washington 12
Abu Qurqas 11
Buffalo 11
Bühl 11
Québec 11
Athens 10
Bari 10
Belize City 10
Mosul 10
Naples 10
Guangzhou 9
Guatemala City 9
Istanbul 9
Iztapalapa 9
Las Vegas 9
Santiago 9
Bogotá 8
Dallas 8
Hamilton 8
Jeju City 8
Konya 8
Mannheim 8
Palermo 8
Phoenix 8
Pune 8
San Nicola la Strada 8
Trieste 8
Vienna 8
Bangkok 7
Cascina 7
Cotonou 7
Cáceres 7
Redwood City 7
Shanghai 7
Sétif 7
Toluca 7
Chicago 6
Falkenstein 6
Ismailia 6
Kunming 6
La Plata 6
Monterrey 6
Orem 6
Rio de Janeiro 6
Santa Cruz de Tenerife 6
Thiruvananthapuram 6
Tuen Mun 6
Totale 16.499
Nome #
Eubiosis and dysbiosis: the two sides of the microbiota 1.092
Influenza A virus infection of intestinal epithelial cells enhances the adhesion ability of Crohn's disease associated Escherichia coli strains 229
Biological and Molecular Characterization of E. coli Strains Isolated from IBD Patients. 209
Poliprotect vs omeprazole in the relief of heartburn, epigastric pain and burning in patients without erosive esophagitis and gastro-duodenal lesions. A randomized, controlled trial 203
Combining amplicon sequencing and metabolomics in cirrhotic patients highlights distinctive microbiota features involved in bacterial translocation, systemic inflammation and hepatic encephalopathy 201
Structural variations of vaginal and endometrial microbiota. Hints on female infertility 197
Role of gut microbiota in the pathogenesis of celiac disease 196
Violacein, an indole-derived purple-colored natural pigment produced by Janthinobacterium lividum, inhibits the growth of head and neck carcinoma cell lines both in vitro and in vivo 194
Dominant Genotypes in Mucosa-Associated Escherichia Coli Strains from Pediatric Patients with Inflammatory Bowel Disease 193
MICROBIOTA COMPOSITION, METABOLIC PROFILES AND INFLAMMATORY HOST RESPONSE AFTER FECAL MICROBIOTA TRANSPLANTATION (FMT) FOR RECURRENT CLOSTRIDIUM DIFFICILE INFECTION. DOES PROTEOBACTERIA ABUNDANCE PREDICT THE RESPONSE TO FMT? 191
Biochemical characterization of the class B acid phosphatase (AphA) of Escherichia coli MG1655 191
The Shigella flexneri OspB effector: an early immunomodulator 188
Adherent-invasive Escherichia coli (AIEC) in pediatric Crohn's disease patients: phenotypic and genetic pathogenic features 187
Protective role of postbiotic mediators secreted by Lactobacillus rhamnosus GG versus Lipopolysaccharide-induced damage in human colonic smooth muscle cells 187
Bacterial biofilm in salivary gland stones: cause or consequence? 186
A distinctive 'microbial signature' in celiac pediatric patients 184
Hyaluronan-cholesterol nanohydrogels: characterisation and effectiveness in carrying alginate lyase 183
Evaluation of microbiota associated with Herpesviruses in active sites of generalized aggressive periodontitis 182
A NEW APPROACH TO USE OF BACTERIOLYTIC ENZYMES AS A TOOL FOR SPECIES IDENTIFICATION - SELECTION OF SPECIES-SPECIFIC INDICATOR STRAINS WITH BACTERIOLYTIC ACTIVITY TOWARDS ENTEROCOCCUS STRAINS 179
Gut microbiota related to Giardia duodenalis, Entamoeba spp. and Blastocystis hominis infections in humans from Côte d'Ivoire. 179
Higher Prevalence and Abundance of Bdellovibrio bacteriovorus in the Human Gut of Healthy Subjects 179
Dominant genotypes in mucosa-associated Escherichia coli strains from pediatric patients with inflammatory bowel disease. 177
Analysis of mucosal bacteria in pediatric patients with inflammatory bowel disease 176
Ala160 and His116 residues are involved in activity and specificity of apyrase, an ATP-hydrolysing enzyme produced by enteroinvasive Escherichia coli 176
Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis 176
Characterization and sequence of PhoC, the principal phosphate-irrepressible acid phosphatase of Morganella morganii. 176
The molecular class C acid phosphatase of Chryseobacterium meningosepticum (OlpA) is a broad-spectrum nucleotidase with preferential activity on 5 '-nucleotides 175
Characterization of mucosa-associated Escherichia coli strains from paediatric patients with inflammatory bowel disease 175
Achromobacter xylosoxidans characteristics important for lung colonization of cystic fibrosis (CF) patients 175
FECAL MICROBIOTA TRANSPLANTATION VIA ENEMA FOR RECURRENT CLOSTRIDIUM DIFFICILE INFECTION MODULATES THE INFLAMMATORY HOST RESPONSE AND RESTORE INTESTINAL DYSBIOSIS 174
Bdellovibrio bacteriovorus directly attacks Pseudomonas aeruginosa and Staphylococcus aureus Cystic fibrosis isolates 174
Achromobacter xylosoxidans Genomic Characterization and Correlation of Randomly Amplified Polymorphic DNA Profiles of Cystic Fibrosis Patients 174
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Allelic Variants Relate to Shifts in Faecal Microbiota of Cystic Fibrosis Patients 173
Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients 172
Bacterial nonspecific acid phosphohydrolases: physiology, evolution and use as tools in microbial biotechnology 169
Effect of lactoferricin on fluoroquinolone susceptibility of uropathogenic Escherichia coli 169
Outbreak of Achromobacter xylosoxidans in an Italian Cystic fibrosis center: genome variability, biofilm production, antibiotic resistance, and motility in isolated strains. 168
Conserved sequence motifs among bacterial, eukaryotic, and archaeal phosphatases that define a new phosphohydrolase superfamily 167
Plasmid-mediated fluoroquinolone resistance determinants in Escherichia coli from community uncomplicated urinary tract infection in an area of high prevalence of quinolone resistance 167
Exposure of E. coli to DNA-methylating agents impairs biofilm formation and invasion of eukaryotic cells via down regulation of the N-acetylneuraminate lyase NanA 167
Microevolution in fimH gene of mucosa-associated Escherichia coli strains isolated from pediatric patients with inflammatory bowel disease 167
Genetic rearrangements in the tyrB-uvrA region of the enterobacterial chromosome: a potential cause for different class B acid phosphatase regulation in Salmonella enterica and Escherichia coli 165
A potential role of Escherichia coli pathobionts in the pathogenesis of pediatric inflammatory bowel disease. 165
The Microbiota in Inflammatory Bowel Disease in Different Age Groups 163
GUT MICROBIOTA AND THE IMMUNE SYSTEM: AN INTIMATE PARTNERSHIP IN HEALTH AND DISEASE 163
Behaviour of Bdellovibrio bacteriovorus in the presence of Gram-positive Staphylococcus aureus. 163
Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease 163
Efficacy of acoustic waves in preventing Streptococcus mutans adhesion on dental unit water line 162
Effect of urban wastewater discharge on the abundance of antibiotic resistance genes and antibiotic-resistant Escherichia coli in two Italian rivers 161
Rhinoviruses promote internalisation of Staphylococcus aureus into non-fully permissive cultured pneumocytes 160
Molecular detection of the predatory bacterium Bdellovibrio bacteriovorus from dental biofilms 160
Heterogeneous patterns of acid phosphatases containing low molecular mass polypeptides in members of the Family Enterobacteriaceae. 159
Bacterial acid phosphatase gene fusions useful as targets for cloning-dependent insertional inactivation 159
Growth control of adherent-invasive Escherichia coli (AIEC) by the Predator Bacteria Bdellovibrio bacteriovorus: a new therapeutic approach for Crohn’s disease patients 159
Production of bacteriolytic enzymes as a tool for characterizing enterococci 158
Species diversity, spatial distribution, and virulence associated genes of culturable vibrios in a brackish coastal Mediterranean environment 157
Antibiotic resistance pattern of extra-intestinal pathogenic escherichia coli isolated in an hospital in Rome. 156
Use of the Morganella morganii phoC Gene as Reporter in Bacterial and Yeast Hosts 154
Dysbiotic Events in Gut Microbiota: Impact on Human Health 153
Biological and molecular characterization of E. coli strains isoltated from inflammatory bowel diseases 152
Differences in the composition of duodenal microbiota in celiac children at diagnosis and after gluten-free diet 152
JC VIRAL REACTIVATION IN A PEDIATRIC PATIENT WITH CROHN'S DISEASE 152
Characterization of mucosa-associated and fecal microbiota of children with austism spectrum disorder 152
Protocolli di verifica della contaminazione batterica e virale in riuniti odontoiatrici: efficacia di dispositivi “anti-cross infection”. 151
Violacein and biofilm production in Janthinobacterium lividum 150
Fecal microbial transplantation impact on gut microbiota composition and metabolome, microbial translocation and T-lymphocyte immune activation in recurrent clostridium difficile infection patients 150
null 149
Encrusted cystitis in an immunocompromised patient: Possible coinfection by Corynebacterium urealyticum and E-coli 147
Insight into the possible use of the predator Bdellovibrio bacteriovorus as a probiotic 147
Listeria monocytogenes in a young patient with non Hodgkin’s lymphoma. 146
Proprieta’ adesive ed invasive di Listeria ivanovii in carenza di ferro e in ambiente acido 142
A method for in vitro simulation of experimental infections due to prostheses 142
VIRULENCE TRAITS IN ESCHERICHIA COLI STRAINS ISOLATED FROM OUTPATIENTS WITH URINARY TRACT INFECTIONS 142
Characterization of mucosa-associated and fecal microbiota of children with autism spectre disorder 142
Rhinovirus promotes internalization of Staphylococcus aureus into airway epithelium favouring opportunistic infections. 141
Caratterizzazione di ceppi di E.coli e Klebsiella spp. isolati da campioni bioptici di pazienti pediatrici affetti da malattie infiammatorie croniche. 140
Expression, purification, crystallization and preliminary X-ray characterization of the class B acid phosphatase (AphA) from Escherichia coli 140
Il virus influenzale aumenta l’adesività di ceppi Escherichia coli isolati da pazienti affetti da malattia di Crohn in cellule intestinali. 140
Protocolli di verifica della contaminazione virale, artificiale e naturale, su riuniti odontoiatrici in uso su pazienti HCV-positivi 139
Chronic intestinal pseudo-obstruction: is there a connection with gut microbiota? 139
Cistite causata da Corynebacterium urealyticum in un soggetto immunocompromesso 138
Cooperazione virus/batteri nella patogenesi delle infezioni opportunistiche del tratto respiratorio, 138
Molecular characterization of intestinal mucosa-associated escherichia col 138
Caratterizzazione di ceppi di Escherichia coli isolati da campioni bioptici di pazienti pediatrici affetti da malattie infiammatorie croniche. 137
Modulation of AtlE gene product by serratiopeptidase reverts Staphylococcus epidermidis biofilm to antibiotic sensibility of the planktonic form. 135
Studio per la definizione e validazione di un nuovo protocollo per la verifica della funzionalità dei sistemi di sterilizzazione e dell’igiene in alta chirurgia e nelle sale operatorie odontoiatriche, mediante amplificazione in vitro degli acidi nucleici con reazione a catena della polimerasi (PCR) 135
Gut Associated Bacterial Microflora in Patients With Inflammatory Bowel Disease (Ibd): Pg5-06 135
Postbiotic Protective Activity of Lactobacillus Rhamnosus GG-Derived Factors on Pathogen Lipopolysaccharide (LPS)-Induced Damage of Human Colonic Smooth Muscle. 134
Strategie terapeutiche innovative basate sulla duplice attività, antibatterica e probiotica, del predatore batterico Bdellovibrio bacteriovorus 134
DOUBLE SUGAR-TYROSINE MEDIUM IMPROVES O-1 PHAGE SALMONELLA SCREENING 133
Cloning and characterization of the NapA acid phosphatase/phosphotransferase of Morganella morganii: identification of a new family of bacterial acid-phosphatase-encoding genes. 133
Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in fecal microbiota of cystic fibrosis patients. 133
Lactoferrin downregulates pro-inflammatory cytokines upexpressed in intestinal epithelial cells infected with invasive or noninvasive Escherichia coli strains 132
Dominant Intestinal Mucosa-Associated Microbiota in Pediatric Patients With Inflammatory Bowel Disease 132
Escherichia coli Population-Based Study in Pediatric Crohn’s Disease 132
Identification of the gene (aphA) encoding the class B acid phosphatase/phosphotransferase of Escherichia coli MG1655 and characterization of its product 132
L'infezione di cellule intestinali con il virus influenzale A promuove l'adesività di ceppi E. Coli isolati da pazienti con malattia di Crohn. 132
Achromobacter xilosoxidans characteristics important for lung colonization of cystic fibrosis (CF) patients. 131
Gut associated bacterial microflora in pediatric patients with inflammatory bowel disease. 128
Correlazione tra presenza di virus influenzali e aumento di E. coli in campioni bioptici prelevati da pazienti pediatrici con morbo di Crohn. 128
Totale 16.982
Categoria #
all - tutte 36.704
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 294
selected - selezionate 0
volume - volumi 0
Totale 36.998


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.225 0 0 0 0 134 242 237 185 152 162 64 49
2020/202111.456 79 57 35 10.326 19 67 26 40 71 97 34 605
2021/20221.465 24 73 118 41 164 44 37 107 159 105 337 256
2022/20231.490 263 271 108 144 171 168 45 88 130 25 37 40
2023/20241.658 48 106 48 143 158 306 127 135 61 211 156 159
2024/2025955 110 237 182 226 200 0 0 0 0 0 0 0
Totale 19.816